We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
472 hedge funds and large institutions have $10.3B invested in United Therapeutics in 2022 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 148 increasing their positions, 159 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
165% more call options, than puts
Call options by funds: $79.5M | Put options by funds: $30M
129% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 41
71% more funds holding in top 10
Funds holding in top 10: 14 → 24 (+10)
32% more capital invested
Capital invested by funds: $7.82B → $10.3B (+$2.5B)
11% more funds holding
Funds holding: 427 → 472 (+45)
0.54% less ownership
Funds ownership: 97.75% → 97.2% (-0.54%)
7% less repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 159
Holders
472
Holders Change
+45
Holders Change %
+10.54%
% of All Funds
7.95%
Holding in Top 10
24
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+71.43%
% of All Funds
0.4%
New
94
Increased
148
Reduced
159
Closed
41
Calls
$79.5M
Puts
$30M
Net Calls
+$49.5M
Net Calls Change
+$32.9M
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$87.8M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.4M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$34.4M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$28.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$26.8M |
